Publications

February 1999 (Revised March 2000)
Case

Beth Israel Deaconess Medical Center: Coordinating Patient Care

External cost pressures are motivating the adoption of case management (CM) at Beth Israel Deaconess Medical Center (BIDMC), but several of the organization's key professional groups are working against it. President and CEO David Dolins must decide whether CM is... View Details

Keywords: Organizational Change and Adaptation; Service Operations; Organizational Culture; Health Care and Treatment; Health Industry; Boston

February 1996 (Revised April 2004)
Case

Eli Lilly and Company: Innovation in Diabetes Care

By: Clayton M. Christensen

Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details

Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry

March 2018
Case

Sandra Brown Goes Digital (A): The Promise and Perils of Social Movements in a Healthcare Company

By: Rosabeth Moss Kanter and Jonathan Cohen

As a middle manager at a biotechnology company, Sandra Brown harnessed digital tools and social media to engage others and build campaigns for change in the company. This case follows her career at the company and describes the challenges she faced as a change agent,... View Details

Keywords: Digital; Engagement; Stakeholder Engagement; Grassroots Movement; Organization Change And Adaptation; Quality; Health Care; Health Care Industry; Career Path; Leading Change; Management; Innovation and Management; Personal Development and Career; Organizational Change and Adaptation; Health Industry; Health Industry

July 2021 (Revised July 2022)
Case

Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care

By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab

Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’... View Details

Keywords: Health Care and Treatment; Outcome or Result; Cost Management; Activity Based Costing and Management; Mobile and Wireless Technology; Health Testing and Trials; Surveys; Health Industry; Boston

April–June 2018
Article

Establishing Teams: How Does It Change Practice Configuration, Size, and Composition?

By: Alyna Chien, Michael Anne Kyle, Antoinette S. Peters, Shalini Tendulkar, Molly Ryan, Karen Hacker and Sara J. Singer

Little is known about how practices reorganize when transitioning from traditional practice organization to team-based care. We compared practice-level (1) configuration as well as practice- and team-level (2) size and (3) composition, before and after establishing... View Details

Keywords: Academic Medicine; Primary Care; Team-based Care; Health Care and Treatment; Groups and Teams; Organizational Change and Adaptation

Register to Read

01 Dec 2007
News

Where Are the Innovators in Health Care?

billion of the excessive costs of U.S. health care while all too many quality measures have worsened. Patients learn — sometimes the hard way — to bring along an assertive, intelligent loved one to protect... View Details

Keywords: Regina E. Herzlinger; Health, Social Assistance; Management

November 2021
Article

Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing

By: Tyler R. McClintock, David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan and George E. Haleblian

Objective. To characterize full cycle of care costs for managing an acute ureteral stone using time-driven activity-based costing.
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details

Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost; Activity Based Costing and Management

October 5, 2017
Article

Making Patients and Doctors Happier—The Potential of Patient-Reported Outcomes

By: Lisa Rotenstein, Robert S. Huckman and Neil Wagle

Keywords: Health Care; Outcomes Measurement; Outcomes Reporting; Quality; Health Industry

Register to Read

March 2019 (Revised June 2021)
Case

HelloSelf: Foundation

By: John R. Wells and Benjamin Weinstock

On January 6, 2019, HelloSelf, a London-based “BrainTech” company, founded a year earlier by Charles Wells, soft launched. The proposition was simply to help its members “Be your Best Self.” The company provided its registered members with access to a clinical... View Details

October 2012
Case

Designing a Culture of Collaboration at Lake Nona Medical City

By: Amy C. Edmondson, Sydney Ribot and Tiona Zuzul

Describes Lake Nona, a 7,000-acre residential and research cluster in central Florida, and its process and innovation culture, and Lake Nona Institute, the organization behind the planning and governance of this new eco-friendly community. Emphasis is placed on the... View Details

Keywords: Collaboration; Innovation; Health Care; Real Estate; Entrepreneurship; Collaborative Innovation and Invention; Governance; Real Estate Industry; Florida

15 Dec 2024
News

Agenda: Amanda E/J Morrison (MBA 2014)

RIPPLE EFFECT “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” For 15 years, the morning-after... View Details

Keywords: Janelle Nanos; reproductive rights; health care; leadership; marketing

March 2014
Editorial

Limits on Use of Health Economic Assessments for Rare Diseases

By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox

Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details

Keywords: Cost; Health Disorders; Health Care and Treatment; Pharmaceutical Industry